2024-09-24 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**Company Overview:** Johnson & Johnson is a multinational pharmaceutical, medical device, and consumer goods company.

**Performance Analysis:**

**1.  Return Comparison:**

*   **JNJ's Cumulative Return:** 36.38%
*   **S&P 500 (VOO) Cumulative Return:** 133.1%
*   **Return Difference:** -96.72%
*   **Relative Divergence:** 7.54% (This indicates that JNJ's performance is currently in the 7.54th percentile of its historical performance relative to the S&P 500.)

**2. Recent Price Action:**

*   **Closing Price:** $163.22
*   **5-Day Moving Average:** $165.06
*   **20-Day Moving Average:** $165.34
*   **60-Day Moving Average:** $158.91

**3. Technical Indicators:**

*   **RSI:** 36.9 (This suggests that JNJ is in oversold territory and may be nearing a potential rebound.)
*   **PPO:** -0.36 (A negative PPO indicates that the price is falling faster than the moving average. This suggests a possible downward trend.)
*   **Delta_Previous_Relative_Divergence:** -3.43 (This indicates a short-term downward trend in JNJ's price action.)
*   **Expected Return:** 13.55% (This represents the estimated maximum return over a 5-year period based on current investment.)

**4. Recent Earnings and Outlook:**

*   **Recent Earnings:**

| Date       | EPS   | Revenue        |
| ---------- | ----- | --------------- |
| 2024-07-25 | 1.95  | $22.45 Billion |
| 2024-05-01 | 1.35  | $21.38 Billion |
| 2024-02-16 | 1.68  | $21.39 Billion |
| 2023-10-27 | 10.32 | $21.35 Billion |
| 2024-02-16 | 10.32 | $21.35 Billion |

*   **Analysis:** JNJ's earnings have been relatively stable in recent quarters, despite slight fluctuations. The most recent earnings report for Q2 2024 showed a slight miss compared to analyst expectations. 

**5. Overall Analysis:**

JNJ has significantly underperformed the S&P 500 in recent years, currently experiencing a considerable gap in performance. While its technical indicators suggest a possible rebound, its recent earnings performance has been relatively stable but with some recent miss compared to analyst expectations. Further analysis is required to determine the future outlook of JNJ.

**6.  Disclaimer:** This analysis is intended for informational purposes only and should not be considered as financial advice.  
